SBIR/STTR Guide: From Phase I Application to Phase III Production Contract, US Defense Group

The SBIR/STTR Guide: How to Turn Federal R&D Dollars into a Production Contract

Most founders hear about SBIR and immediately think “government grants.” That framing is both correct and misleading. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs collectively distribute $4 to $6 billion annually in non-dilutive funding across 11 federal agencies (Source: SBIR.gov, U.S. Small Business Administration, 2026). That funding is real. But the program is not a grant in the philanthropic sense. It is a structured pipeline designed to move commercial technology from concept to government adoption, and the companies that treat it as a pipeline (rather than a windfall) are the ones that reach production contracts.

This guide walks you through each phase, the critical transition points, and the strategic decisions that separate the roughly 5% of awardees who reach Phase III from the 95% who do not.

What SBIR and STTR Actually Are

SBIR and STTR are congressionally mandated set-aside programs. Every federal agency with an extramural research and development budget exceeding $100 million must allocate 3.2% of that budget to SBIR and 0.45% to STTR (Source: About SBIR and STTR, SBA, 2026). That statutory requirement creates a reliable, recurring pool of capital that is not subject to the year-to-year discretionary budget fights that affect most government spending.

The two programs differ in one important structural respect. SBIR awards go directly to small businesses. STTR awards require a formal partnership with a research institution (university, federal lab, or nonprofit research organization), which must perform at least 30% of the work in Phase I and 40% in Phase II.

Reauthorization through 2031. On April 13, 2026, President Trump signed the Small Business Innovation and Economic Security Act of 2026 (S. 3971), extending SBIR/STTR authority through September 30, 2031 (Source: Congress Reauthorizes the SBIR and STTR Programs, IEDC, April 2026). This five-year window eliminates the recurring reauthorization crises that disrupted the program in 2022, 2023, and 2025 (the programs lapsed for six months between October 2025 and April 2026). For companies planning multi-year technology development, the stability matters.

The Three Phases (and the New Fourth Tier)

Phase I: Feasibility (6 to 12 months)

Phase I is a proof-of-concept study. You are demonstrating that your technology approach is scientifically sound and worth further investment.

Typical award: $50,000 to $275,000 depending on the agency. The SBA-approved guideline ceiling is $323,090 per award including modifications (Source: Policies, SBIR.gov, 2026).
Duration: Usually 6 to 12 months.
What you deliver: A final report demonstrating technical feasibility, preliminary results, and a plan for Phase II development.
Success metric: Did the core technical approach work? Can you articulate a credible path to a prototype?

Agency-specific amounts vary significantly. AFWERX (the Air Force innovation arm) caps Phase I SBIR at $75,000 and STTR at $110,000, while the National Institutes of Health may award up to $275,000 (Source: AFWERX Get Funded, AFWERX, 2026).

Phase II: Prototype Development (Up to 24 months)

Phase II is full research and development. You are building a working prototype and demonstrating it in a relevant environment.

Typical award: $500,000 to $1.75 million. The SBA-approved ceiling is $2,153,927 per award including modifications (Source: Policies, SBIR.gov, 2026).
Duration: Up to 24 months, with some agencies allowing extensions.
What you deliver: A functional prototype, test data, and a detailed commercialization plan.
Success metric: Does the prototype work? Is there a customer (government or commercial) ready to buy it?

Phase II is where most of the technical risk gets retired. It is also where the commercialization planning should begin in earnest, not as an afterthought but as a core deliverable.

Phase III: Commercialization (No Set-Aside, No Dollar Cap)

Phase III is not a “phase” in the way most founders understand it. There is no Phase III solicitation. There is no set-aside. Phase III is simply the designation for any follow-on work, funded by the agency’s operational budget or by private capital, that commercializes the technology developed in Phase I and II.

Award amount: Unlimited. Phase III contracts are funded from the agency’s regular procurement budget.
Duration: Varies. Production contracts can run for years.
Key advantage: Phase III contracts are sole-source eligible. The agency does not have to compete the follow-on work if it derives from a SBIR/STTR Phase I or II award. This is one of the most underutilized provisions in the program.

The transition from Phase II to Phase III is where most companies fail. Understanding why, and what to do about it, is the subject of the next section.

Strategic Breakthrough Awards: The New Post-Phase II Bridge

The 2026 reauthorization created a new funding mechanism specifically designed to address the Phase II-to-III gap. Strategic Breakthrough Awards allow agencies to make awards of up to $30 million per company over performance periods of up to 48 months (Source: SBIR/STTR Reauthorization Passes Congress, Granted AI, 2026).

The catch: companies must provide 100% matching funds from non-SBIR sources (200% for DoD, with at least 20% from new non-SBIR DoD funding). This is not free money. It is structured co-investment designed to ensure that companies with real commercialization traction can access the capital needed to cross the valley of death.

The Valley of Death: Why 95% of Phase II Awardees Never Reach Production

The gap between a Phase II prototype and a production contract has been the program’s most persistent failure mode for four decades. The defense innovation community calls it the “valley of death,” and the metaphor is not dramatic. It is descriptive (Source: Once More into the Valley of Death, KJK, April 2026).

The valley exists for structural, not technical, reasons:

Timing mismatch. Phase II ends. The technology works. But the program of record that would buy it is two budget cycles away. The company runs out of runway waiting.
Acquisition inertia. Program managers have existing contracts with established primes. Inserting a new technology from a small business requires effort, risk tolerance, and paperwork that no one is incentivized to take on.
Commercialization planning deficit. Many companies treat SBIR as an R&D program and defer commercial strategy until after Phase II. By then, it is too late to build the relationships and requirements alignment needed for a Phase III transition.
Capital gap. Phase II ends at $1-2 million. The next contract might be $10-50 million. Banks will not lend against government contracts the company does not yet have. VCs are often unfamiliar with the defense acquisition timeline.

What the Companies That Cross the Valley Do Differently

The companies that reach Phase III share a common pattern. They begin commercialization planning in Phase I. They identify the program of record, the program manager, and the requirements document before Phase II ends. They build relationships with the primes who will eventually integrate their technology. And they secure bridge capital (whether through STRATFI, venture debt, or the new Strategic Breakthrough Awards) before the Phase II money runs out.

Finding Topics and Submitting Proposals

Where to Find Open Topics

All SBIR/STTR solicitations are posted on SBIR.gov. Each participating agency issues a Program Solicitation containing R&D topics and subtopics. The Department of Defense posts topics through the Defense SBIR/STTR Innovation Portal (DSIP) at dodsbirsttr.mil.

AFWERX, the Air Force’s innovation arm, is the single largest source of SBIR awards, having issued more than 10,400 contracts worth over $7.24 billion since 2019 and approximately 1,400 contracts totaling over $1.4 billion annually (Source: AFWERX Get Funded, AFWERX, 2026). In FY2025 alone, AFWERX awarded more than 1,000 contracts totaling $1.37 billion and achieved 438 Phase III transitions valued at $8.1 billion (Source: AFWERX News, AFWERX, 2026).

The Direct to Phase II Option

If your company has already demonstrated Phase I feasibility using non-SBIR funds (internal R&D, commercial revenue, private investment), you may be eligible for a Direct to Phase II (D2P2) award. This pathway lets you skip Phase I entirely and enter the program at the prototyping stage (Source: FAQ and Resources, Army SBIR, 2026).

Key requirements for D2P2:

You must demonstrate that Phase I-equivalent work has been completed.
The feasibility documentation must not be derived from prior SBIR/STTR work.
The technology should leverage capability readily available in the commercial market.

D2P2 is particularly well suited for venture-backed companies that have already built a product for the commercial market and want to adapt it for government use.

Proposal Structure

While specific requirements vary by agency, most Phase I proposals follow a common structure:

Technical Approach (the core of the proposal): What is the innovation? What is the technical risk? How will you retire it during Phase I?
Key Personnel: Who will do the work? What is their relevant experience?
Prior Work and Feasibility: What have you already demonstrated?
Commercialization Plan: Even in Phase I, agencies want to see a credible path to adoption. Who will buy this? How big is the market?
Budget and Schedule: Realistic cost estimates and milestones.

The commercialization plan is not a formality. Reviewers increasingly weight commercialization potential as heavily as technical merit. A brilliant technology with no path to adoption will lose to a good technology with a clear customer.

The SBIR/STTR Ecosystem: Key Programs and Accelerators

Several programs exist to help companies navigate the SBIR pipeline more effectively:

AFWERX STRATFI (Strategic Financing): Matches SBIR Phase II funding with private capital and government operational funding, with awards ranging from $3M to $15M over up to 48 months (Source: STRATFI Notice of Opportunity, AFWERX, 2026).
AFWERX TACTFI (Tactical Financing): Smaller-scale transition funding for near-term operational needs.
APFIT (Accelerate the Procurement and Fielding of Innovative Technologies): A DoD-wide program that crossed $1 billion in cumulative awards in 2026 (Source: Pentagon Crosses $1B in APFIT Awards, Granted AI, 2026).

New Security Screening Requirements

The 2026 reauthorization introduced enhanced security screening for SBIR/STTR applicants. Agencies must now conduct national security and supply chain due diligence before making awards, including examining whether an applicant has foreign affiliations with entities located in a country of concern (Source: SBIR/STTR Reauthorization Passes Congress, Granted AI, 2026).

Companies with foreign ownership, control, or influence (FOCI) should proactively assess their eligibility before investing time in a proposal. This is not a barrier for most U.S. small businesses, but it requires awareness and documentation.

How US Defense Group Can Help

The SBIR/STTR pipeline is a powerful capital source, but it rewards companies that understand the defense acquisition ecosystem, not just companies with strong technology. US Defense Group works with dual-use technology companies at every stage of the SBIR lifecycle:

Topic identification and alignment: Matching your technology to the right agency, the right topic, and the right program of record.
Proposal strategy: Structuring proposals that score well on both technical merit and commercialization potential.
Phase II-to-III transition planning: Building the relationships, requirements alignment, and bridge capital strategy needed to cross the valley of death.
STRATFI and APFIT positioning: Helping companies access the larger transition funding programs that sit between SBIR Phase II and full production.

Launcher Station, the accelerator operated by US Defense Group, specifically focuses on helping dual-use technology companies navigate the defense market entry process, including SBIR/STTR strategy as part of a broader go-to-market plan.

Next Steps

The SBIR/STTR program is one of the most reliable sources of non-dilutive capital available to technology companies in the United States. But the companies that capture the most value from the program are the ones that treat it as a market entry strategy, not a grant application.

If you are building technology with defense or dual-use applications, understanding how SBIR/STTR fits into a broader government market strategy is one of the highest-leverage investments you can make.

Sources

Questions about SBIR and STTR programs

What is the difference between SBIR and STTR?

Both programs fund small business research and development, but STTR requires the small business to partner formally with a nonprofit research institution. SBIR permits research partners but does not require that institutional partnership.

Source: SBIR.gov, Program Basics

How do SBIR and STTR phases work?

Phase I evaluates technical merit and feasibility, Phase II continues research and development, and Phase III moves the resulting technology toward commercialization or government use with funding outside the SBIR and STTR programs. Individual agencies publish their own topics, schedules, and award terms.

Source: SBIR.gov, Apply

Last reviewed July 13, 2026, by US Defense Group Editorial Team.

SBIR/STTR Guide: From Phase I Application to Phase III Production Contract